Efficacy and safety of a third SARS-CoV-2 vaccination in multiple sclerosis vaccine non-responders

Marton König; Hilde Marie Torgauten; Mathias Herstad Øverås; Adity Chopra; Åslaug Rudjord Lorentzen; The Trung Tran; Siri Mjaaland; Ingeborg Sundsvalen Aaberge; Kjell-Morten Myhr; Stig Wergeland; Tone Berge; Hanne Flinstad Harbo; Øivind Fredvik Torkildsen; Trygve Holmøy; Elisabeth Gulowsen Celius; Ludvig Andre Munthe; John Torgils Vaage; Fridtjof Lund-Johansen; Gro Owren Nygaard

doi:10.1101/2021.10.15.21264977

Efficacy and safety of a third SARS-CoV-2 vaccination in multiple sclerosis vaccine non-responders

View ORCID ProfileMarton König, Hilde Marie Torgauten, Mathias Herstad Øverås, Adity Chopra, Åslaug Rudjord Lorentzen, The Trung Tran, View ORCID ProfileSiri Mjaaland, View ORCID ProfileIngeborg Sundsvalen Aaberge, View ORCID ProfileKjell-Morten Myhr, View ORCID ProfileStig Wergeland, View ORCID ProfileTone Berge, View ORCID ProfileHanne Flinstad Harbo, Øivind Fredvik Torkildsen, Trygve Holmøy, View ORCID ProfileElisabeth Gulowsen Celius, View ORCID ProfileLudvig Andre Munthe, View ORCID ProfileJohn Torgils Vaage, View ORCID ProfileFridtjof Lund-Johansen, View ORCID ProfileGro Owren Nygaard

doi: https://doi.org/10.1101/2021.10.15.21264977

Marton König

1Oslo University Hospital, Department of Neurology, Oslo, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Marton König
For correspondence: makoni@ous-hf.no

Hilde Marie Torgauten

2Neuro-SysMed, Department of Neurology, Haukeland University Hospital

3University of Bergen, Department of Clinical Medicine

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mathias Herstad Øverås

1Oslo University Hospital, Department of Neurology, Oslo, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Adity Chopra

4Oslo University Hospital, Department of Immunology, Oslo, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Åslaug Rudjord Lorentzen

5Sørlandet Hospital, Department of Neurology, Kristiansand, Norway

6Sørlandet Hospital, The Norwegian National Advisory Unit on Tick-borne diseases, Arendal, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

The Trung Tran

4Oslo University Hospital, Department of Immunology, Oslo, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Siri Mjaaland

7Norwegian Institute of Public Health, Division of Infection Control, Oslo, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Siri Mjaaland

Ingeborg Sundsvalen Aaberge

7Norwegian Institute of Public Health, Division of Infection Control, Oslo, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Ingeborg Sundsvalen Aaberge

Kjell-Morten Myhr

2Neuro-SysMed, Department of Neurology, Haukeland University Hospital

3University of Bergen, Department of Clinical Medicine

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Kjell-Morten Myhr

Stig Wergeland

2Neuro-SysMed, Department of Neurology, Haukeland University Hospital

8Norwegian MS Registry and Biobank, Haukeland University Hospital, Bergen, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Stig Wergeland

Tone Berge

9Oslo Metropolitan University, Department of Mechanical, Electronic and Chemical Engineering, Oslo, Norway

10Oslo University Hospital, Department of Research, Innovation and Education, Division of Clinical Neuroscience, Oslo, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Tone Berge

Hanne Flinstad Harbo

1Oslo University Hospital, Department of Neurology, Oslo, Norway

11University of Oslo, Institute of Clinical Medicine, Oslo, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Hanne Flinstad Harbo

Øivind Fredvik Torkildsen

2Neuro-SysMed, Department of Neurology, Haukeland University Hospital

3University of Bergen, Department of Clinical Medicine

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Trygve Holmøy

11University of Oslo, Institute of Clinical Medicine, Oslo, Norway

12Akershus University Hospital, Department of Neurology, Oslo, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Elisabeth Gulowsen Celius

1Oslo University Hospital, Department of Neurology, Oslo, Norway

11University of Oslo, Institute of Clinical Medicine, Oslo, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Elisabeth Gulowsen Celius

Ludvig Andre Munthe

4Oslo University Hospital, Department of Immunology, Oslo, Norway

13University of Oslo, KG Jebsen Centre for B cell malignancy, Oslo, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Ludvig Andre Munthe

John Torgils Vaage

4Oslo University Hospital, Department of Immunology, Oslo, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for John Torgils Vaage

Fridtjof Lund-Johansen

4Oslo University Hospital, Department of Immunology, Oslo, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Fridtjof Lund-Johansen

Gro Owren Nygaard

1Oslo University Hospital, Department of Neurology, Oslo, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Gro Owren Nygaard

Abstract
Full Text
Info/History
Metrics
Data/Code
Preview PDF

Article usage

Article usage: October 2021 to May 2022

	Abstract	Full	Pdf
Oct 2021	1862	19	370
Nov 2021	604	11	115
Dec 2021	270	4	62
Jan 2022	203	12	50
Feb 2022	115	19	31
Mar 2022	65	12	18
Apr 2022	65	1	14
May 2022	33	1	6

View the discussion thread.

PreviousNext

Posted October 18, 2021.

Download PDF

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Efficacy and safety of a third SARS-CoV-2 vaccination in multiple sclerosis vaccine non-responders

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Efficacy and safety of a third SARS-CoV-2 vaccination in multiple sclerosis vaccine non-responders

Marton König, Hilde Marie Torgauten, Mathias Herstad Øverås, Adity Chopra, Åslaug Rudjord Lorentzen, The Trung Tran, Siri Mjaaland, Ingeborg Sundsvalen Aaberge, Kjell-Morten Myhr, Stig Wergeland, Tone Berge, Hanne Flinstad Harbo, Øivind Fredvik Torkildsen, Trygve Holmøy, Elisabeth Gulowsen Celius, Ludvig Andre Munthe, John Torgils Vaage, Fridtjof Lund-Johansen, Gro Owren Nygaard

medRxiv 2021.10.15.21264977; doi: https://doi.org/10.1101/2021.10.15.21264977

Share This Article: